Skip to main content
. 2021 Apr 17;13(4):575. doi: 10.3390/pharmaceutics13040575

Figure 3.

Figure 3

Cytocidal activity of BSA-Silver NPs: (A) cell viability profiles of B16F10 cells after treatment of either silver ions or BSA-Silver NPs. (B) Reactive oxygen species (ROS) generation assay results. The statistically significant differences in the cytotoxicity levels were compared by 1-way ANOVA (Tukey’s multiple comparison test as the post hoc test). ** p < 0.01, *** p < 0.001 vs. PBS control. (BSA-Silver NP: BSA-coated silver nanoparticles).